Browsing: Orsini

ELK GROVE VILLAGE, Ill., Aug. 28, 2026 /PRNewswire/ — Orsini, a leader in rare disease pharmacy solutions, announced today that it is a specialty pharmacy partner for Priovant’s LISRAYA™ (brepocitinib), a once-daily oral therapy for the treatment of adults with dermatomyositis. Read the full Prescribing Information here. See the Important Safety Information and Boxed Warning below…